Avner Yayon

Avner Yayon


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
DCD. Correa
D. Correa
Rodrigo SomozaRodrigo Somoza
Rodrigo Somoza
PLP. Lin
P. Lin
SGS. Greenberg
S. Greenberg
ERE. Rom
E. Rom
ACA.I. Caplan
A.I. Caplan

1 January 2020 in Acta Biomaterialia
Verified
Journal Article
Closed access
MVMaria Letizia Vainieri
Maria Letizia Vainieri
ALAndrea Lolli
Andrea Lolli
NKN. Kops
N. Kops
DDD. D'ATri
D. D'ATri
DED. Eglin
D. Eglin
GOGerjo J.V.M. Van Osch
Gerjo J.V.M. Van Osch

1 March 2020 in Acta Biomaterialia
Verified
Journal Article
Closed access
BABernardo P. Antunes
Bernardo P. Antunes
MVM. Letizia Vainieri
M. Letizia Vainieri
MAMauro Alini
Mauro Alini
EMEfrat Monsonego-Ornan
Efrat Monsonego-Ornan
Sibylle GradSibylle Grad
Sibylle Grad
AYAvner Yayon
Avner Yayon

Verified
Journal Article
Open access
PDF file
SHSonja Häckel
Sonja Häckel
MZMona Zolfaghar
Mona Zolfaghar
JDJie Du
Jie Du
SHSven Hoppe
Sven Hoppe
LBLorin M. Benneker
Lorin M. Benneker
ZLZhen Li
Zhen Li
We investigated the effects of a fibrin-hyaluronic acid hydrogel (FBG–HA) and fibroblast growth factor 18 (FGF-18) for nucleus pulposus (NP) regeneration. Healthy bovine (n = 4) and human degenerated NP cells (n = 4) were cultured for 14 days in FBG-HA hydrogel with FGF-18 (∆51-mutant or wild-type) in the culture medium. Gene expression, DNA content, and glycosaminoglycan (GAG) synthesis were evaluated on day 7 and 14. Additionally, histology was performed. Human NP cells cultured in FBG-HA hydrogel showed an increase in collagen type II (COL2) and carbonic anhydrase XII (CA12) gene expression after 14 or 7 days of culture, respectively. GAG release into the conditioned medium increased over 14 days. Healthy bovine NP cells showed increased gene expression of ACAN from day 7 to day 14. Wild type FGF-18 up-regulated CA12 gene expression of human NP cells. Histology revealed an increase of proteoglycan deposition upon FGF-18 stimulation in bovine but not in human NP cells. The FBG-HA hydrogel had a positive modulatory effect on human degenerated NP cells. Under the tested conditions, no significant effect of FGF-18 was observed on cell proliferation or GAG synthesis in human NP cells.

1 July 2020 in Heliyon
Verified
Journal Article
Open access
LKLeonid Kandel
Leonid Kandel
GAGabriel Agar
Gabriel Agar
OEOri Elkayam
Ori Elkayam
ASAybek Sharipov
Aybek Sharipov
OSOmer Slevin
Omer Slevin
AYAvner Yayon
Avner Yayon
Osteoarthritis (OA) is a widespread degenerative joint disease leading to progressive loss of function and pain. Available treatments do not provide long-term relief or improvement. This study aimed to assess the safety and efficacy of a novel intra articular supplement, made of high molecular-weight hyaluronic acid (HA) uniquely conjugated to either purified (RegenoGel) or autologous plasma-derived fibrinogen (RegenoGel-OSP), as a long-term treatment for knee OA. Sixty-seven consecutive participants (mean age 67.26 ± 7 years) with symptomatic OA were randomly assigned to receive intraarticular injections of either RegenoGel, RegenoGel-OSP or saline solution (placebo). The active treatment groups received a second, repeat injection of the corresponding treatment at the 3-month evaluation, at which time, the placebo group was divided into two subgroups, one receiving RegenoGel and the other receiving RegenoGel-OSP. The OA symptoms were assessed by VAS, WOMAC, and IKDC questionnaires at baseline and at 1, 3, 4, and 6 months following the first injection. OA-related quality of life was evaluated by the SF-12 survey. Our preliminary data suggests that both fibrin-HA formulations have positive effects on OA symptoms for all assessed parameters with the most prominent trend for reduction in OA-associated pain. Pooled data analysis of RegenoGel and RegenoGel-OSP shows significantly improved VAS scores compared to placebo at three months after the first injection, and sustained for another three months after the second injection. Both RegenoGel, RegenoGel-OSP had an excellent safety profile. Interim analysis results indicate that RegenoGel and RegenoGel-OSP are safe and are potentially effective for at least six months in alleviating pain and symptoms of knee OA.

6 August 2020 in Polymers
Verified
Journal Article
Open access
PDF file
MVMaria Letizia Vainieri
Maria Letizia Vainieri
MAMauro Alini
Mauro Alini
AYAvner Yayon
Avner Yayon
GOGerjo J.V.M. Van Osch
Gerjo J.V.M. Van Osch
Sibylle GradSibylle Grad
Sibylle Grad
Cell migration has a central role in osteochondral defect repair initiation and biomaterial-mediated regeneration. New advancements to reestablish tissue function include biomaterials and factors promoting cell recruitment, differentiation and tissue integration, but little is known about responses to mechanical stimuli. In the present pilot study, we tested the influence of extrinsic forces in combination with biomaterials releasing chemoattractant signals on cell migration. We used an ex vivo mechanically stimulated osteochondral defect explant filled with fibrin/hyaluronan hydrogel, in presence or absence of platelet-derived growth factor-BB or stromal cell-derived factor 1, to assess endogenous cell recruitment into the wound site. Periodic mechanical stress at early time point negatively influenced cell infiltration compared to unloaded samples, and the implementation of chemokines to increase cell migration was not efficient to overcome this negative effect. The gene expression at 15 days of culture indicated a marked downregulation of matrix metalloproteinase (MMP)13 and MMP3, a decrease of β1 integrin and increased mRNA levels of actin in osteochondral samples exposed to complex load. This work using an ex vivo osteochondral mechanically stimulated advanced platform demonstrated that recurrent mechanical stress at early time points impeded cell migration into the hydrogel, providing a unique opportunity to improve our understanding on management of joint injury.